Method of treating chronic herpes virus infections using an opia

Details Method of treating chronic herpes virus infections using an opia Method of treating chronic herpes virus infections using an opia

1993-05-10

1994-10-18

Hollinden, Gary E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514934, A61K 3144

Patent

active

053569008

ABSTRACT:
Chronic herpes virus infections are treated in human patients by the administration by a pharmacologically effective mode or route of an essentially pure opiate receptor antagonist, preferably an essentially pure opiate receptor antagonist exhibiting substantially higher blocking action against Mu opiate receptor sites than against Delta receptor sites, exemplified by Naltrexone and Naloxone, at a low dose concentration which produces therapeutic results corresponding to those produced by Naltrexone when administered in the range of 1 mg to 10 mg and at which Delta receptor blocking activity is at most small while Mu receptor blocking activity is significant and most preferably exclusive.

REFERENCES:
patent: 4537878 (1985-08-01), Plotnikoff
patent: 4927832 (1990-05-01), Clemence et al.
patent: 4956355 (1990-09-01), Prendergast

Affiliated with

Also associated with

Rating

Method of treating chronic herpes virus infections using an opia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating chronic herpes virus infections using an opia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating chronic herpes virus infections using an opia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2372630